TELADOC HEALTH INC
TDOCNYSETrading Snapshot
- Day Range
- $5.70 – $5.80
- 52-Week Range
- $4.40 – $9.89
- Volume
- $2.00B
- Avg Volume
- $2.54B
- Shares Outstanding
- 181.7M
- Next Earnings
- Nov 7, 2026
Fundamentals Snapshot
- Annual Revenue
- $2.53B
- Last Q Revenue
- $607M
- P/E Ratio
- -6.2
- P/S Ratio
- 0.4x
- EPS (TTM)
- $-0.99
- Dividend Yield
- 0.00%
- Dilution (1yr)
- +2.0%
Why Investors Own TDOC
- ✓High-growth profile — revenue up -0.9% YoY with expanding US Equity exposure.
- ✓Healthy economics — 60% gross margin and 14% free-cash-flow margin.
- ✓New products and segments could unlock additional revenue streams.
Execution delays, intensifying competition, and valuation compression if growth decelerates.
TELADOC HEALTH INC
TDOC
StockOtter · stockotter.spaceAbout TELADOC HEALTH INC
Teladoc Health, Inc. offers remote medical services to individuals both domestically in the United States and internationally. Their extensive range of solutions covers a wide array of health needs, from routine and acute conditions to complex and long-term illnesses such as diabetes, hypertension, chronic kidney disease, cancer, congestive heart failure, and various mental health issues. The company delivers numerous programs, including virtual primary and specialized medical care, management for chronic diseases, expert second opinion services, mental wellness support, and core platform and service offerings. They serve a diverse client base, including corporations, health insurance providers, hospitals and healthcare systems, financial service companies, and individual patients. The Teladoc, Livongo, and BetterHelp brands fall under their purview. Founded in 2002, the company, which operated as Teladoc, Inc. until its renaming in August 2018, is based in Purchase, New York.
Otter Score Breakdown
How it's scoredFive components, each rated 1–5★ and equally weighted (20%), averaged to a 0–100 score:💎 Quality — gross margin🚀 Growth — revenue YoY⚖️ Valuation — P/S ratio⚡ Momentum — 30-day price change💧 Dilution — 1-yr share issuance (buybacks score higher)Analyst Ratings
ⓘLatest News & Updates
171,447 Teladoc Health, Inc. $TDOC Shares Sold by Corient Private Wealth LP
Corient Private Wealth LP trimmed its holdings in shares of Teladoc Health, Inc. (NYSE: TDOC) by 62.8% in the undefined quarter, according to its most recent disclosure with the SEC. The fund owned 101,556 shares of the
Teladoc Health Announces Chief Legal Officer Transition
Jonathan Dorfman to be promoted to Chief Legal Officer and Secretary effective November 2, 2026 Jonathan Dorfman to be promoted to Chief Legal Officer and Secretary effective November 2, 2026
Teladoc (TDOC) Registers a Bigger Fall Than the Market: Important Facts to Note
Teladoc (TDOC) closed the most recent trading day at $6.13, moving 3.46% from the previous trading session.
Teladoc (TDOC) Stock Slides as Market Rises: Facts to Know Before You Trade
Teladoc (TDOC) concluded the recent trading session at $6.28, signifying a -2.33% move from its prior day's close.
Teladoc: Integrated Care And Free Cash Flow Could Bring It Back To Life
Teladoc Health trades near multi-year lows, with the market pricing in deep distress despite meaningful free cash flow and manageable debt. BetterHelp's rapid decline drags on TDOC, but Integrated Care's improving margin
Why Teladoc (TDOC) Outpaced the Stock Market Today
Teladoc (TDOC) reached $6.16 at the closing of the latest trading day, reflecting a +1.15% change compared to its last close.